Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.
about
Molecular cloning, expression, and partial characterization of two novel members of the ovalbumin family of serine proteinase inhibitorsMethotrexate in rheumatoid arthritis: a quarter century of developmentUpsides and downsides of reactive oxygen species for cancer: the roles of reactive oxygen species in tumorigenesis, prevention, and therapyPhase II trial of oral aminopterin for adults and children with refractory acute leukemiaEmerging drugs for uveitisAn evaluation of folic acid antagonists in adults with neoplastic diseases: a study of 93 patients with incurable neoplasmsProgress in childhood cancer: 50 years of research collaboration, a report from the Children's Oncology GroupCancer chemotherapy: past, present, and future--Part IOne-Carbon Metabolism in Prostate Cancer: The Role of Androgen SignalingOff-label use of targeted therapies in oncologySerine, glycine and one-carbon units: cancer metabolism in full circleIs cancer a metabolic disease?Serine and glycine metabolism in cancerOral and dental considerations in pediatric leukemic patientAntigen-based immunotherapy for the treatment of acute lymphoblastic leukemia: the emerging role of blinatumomabMercaptopurine/Methotrexate maintenance therapy of childhood acute lymphoblastic leukemia: clinical facts and fictionStructures of human folate receptors reveal biological trafficking states and diversity in folate and antifolate recognitionPharmacogenomics in Pediatric Oncology: Review of Gene-Drug Associations for Clinical UseTargeted killing of a mammalian cell based upon its specialized metabolic stateMethotrexate Is a JAK/STAT Pathway InhibitorMusic, medicine, and modus moriendi.Targeting DNA Mismatches with Rhodium Metalloinsertors.Crystal structure of avian aminoimidazole-4-carboxamide ribonucleotide transformylase in complex with a novel non-folate inhibitor identified by virtual ligand screening.Antimetabolites and cancer: emerging data with a focus on antifolates.Biology-driven cancer drug development: back to the futureOne-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy.Molecular and cellular correlates of methotrexate response in childhood acute lymphoblastic leukemia.Evolution of acquired resistance to anti-cancer therapy.Genetic Mutations and Epigenetic Modifications: Driving Cancer and Informing Precision Medicine.Emil "Tom" Frei III, MD (1924-2013)Cats, frogs, and snakes: early concepts of neural tube defects.Evolutionary dynamics of carcinogenesis and why targeted therapy does not work.Pemetrexed in advanced non-small-cell lung cancer.Leukaemia - a brief historical review from ancient times to 1950.Therapeutic targeting of a novel 6-substituted pyrrolo [2,3-d]pyrimidine thienoyl antifolate to human solid tumors based on selective uptake by the proton-coupled folate transporterPemetrexed disodium in ovarian cancer treatment.The human proton-coupled folate transporter: Biology and therapeutic applications to cancer.Targeting the proton-coupled folate transporter for selective delivery of 6-substituted pyrrolo[2,3-d]pyrimidine antifolate inhibitors of de novo purine biosynthesis in the chemotherapy of solid tumors.Systemic methotrexate therapy for psoriasis: past, present and future.Therapeutic Targeting of Myc.
P2860
Q24312918-18B61088-F847-4BB9-8BFC-F2B14EDE0634Q24597346-9BDC30FF-FCB8-4980-9803-60982CE3279FQ24597964-7166F691-BE33-4E90-A9C8-E58E858B520BQ24606434-986EB611-4DBC-435A-8605-9E1C2878DF81Q24630848-C205C46B-FFAE-45F4-A8EC-14B08DB1B3EBQ24651968-982D9A59-4709-422F-AFB5-A901F019B0DEQ24657000-94ACC562-59EE-4CE8-A0DC-D8ABB2E61D76Q24657512-B2F0B5CA-92E7-4EB1-9185-4FDB23A90E74Q26740548-60F06C2E-0CD4-4857-AA3E-3190427DCBA6Q26747685-2667A87F-9F8B-4F95-B0B9-00DF4105A3E6Q26828610-11BEF11D-D5DA-494A-A046-449AE4A6C5ABQ26852241-CB3ED87D-F902-48B9-AABB-43649B5C9FEBQ26863700-56C4E3AE-0DCB-41EF-B6C4-0C48CEEE4A82Q27000488-4438B238-61FF-4CA3-AC35-34B93C681F73Q27013710-D2968632-0590-46A2-87DC-0D661FFA6BFBQ27023839-B2E1673B-A986-4F97-A409-7CF1470652B6Q27679502-F253567F-68C6-4416-9484-5E9EEFD648D9Q28068930-908EA6D8-F8FE-4C78-835F-1B251F50CE14Q28511658-3C5C8EB2-4E67-478A-8938-EE17E7E1C92DQ28546079-20AA613F-4E04-4DF5-8D35-546092E0DDB4Q30312655-E59169D0-C476-495E-B825-5ACED1B3AD8EQ31136996-1ACADE64-5F20-4EF7-9EA5-0C731A830E58Q33206581-996D9C86-3072-4121-8FED-70744C9993B6Q33530405-30BDA17E-5B1F-41A2-BEBE-082C3E1BF24EQ33552888-3FC5E8C6-1EFC-4B02-86F0-981A0C628634Q33618935-B1937072-9176-4C9B-9B26-6C4F4ABCAC3CQ33747235-CD836083-0BC9-435E-943E-361876B2E859Q33758382-4B5F2447-C487-4AEB-962C-AC6F9FE63BFAQ33823065-0ADB6AF4-800C-4848-BCFE-BF2AD0D583C3Q33841495-FB8DC89B-D002-4935-A192-2214DEA03A22Q33951478-E4917DBE-1323-4D6F-AD1A-21C729E92DFDQ34005286-21F34733-C111-4411-ACE5-2E362850328EQ34113895-E35E4C16-3006-461E-9B10-4CC13E6F3903Q34135337-1C24E903-D76B-4960-BE64-82AA82010A19Q34218576-39BF4AC3-1AD4-4ECF-B546-9EA80C5755A0Q34253505-7D5D4935-941E-4D7C-A944-13971F5436CDQ34297931-0872C5D7-269C-4A62-A15A-B4D8F9650743Q34310128-9C254814-69B4-4180-9AB1-50F617B1BEC8Q34356265-C8B4AFF3-B3C9-4751-875F-9E20EED95C66Q34373258-99E9D143-BE1E-4921-859F-3A0B563D6BDF
P2860
Temporary remissions in acute leukemia in children produced by folic acid antagonist, 4-aminopteroyl-glutamic acid.
description
1948 nî lūn-bûn
@nan
1948 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
1948 թվականի հունիսին հրատարակված գիտական հոդված
@hy
1948年の論文
@ja
1948年学术文章
@wuu
1948年学术文章
@zh-cn
1948年学术文章
@zh-hans
1948年学术文章
@zh-my
1948年学术文章
@zh-sg
1948年學術文章
@yue
name
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@ast
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@en
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@nl
type
label
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@ast
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@en
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@nl
prefLabel
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@ast
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@en
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@nl
P1476
Temporary remissions in acute ...... 4-aminopteroyl-glutamic acid.
@en
P2093
P304
P356
10.1056/NEJM194806032382301
P407
P577
1948-06-01T00:00:00Z